Literature DB >> 19931949

Structure-activity relationships and mechanism of action of antitumor bis 8-hydroxyquinoline substituted benzylamines.

Sébastien Madonna1, Christophe Béclin, Younes Laras, Vincent Moret, Aline Marcowycz, Delphine Lamoral-Theys, Jacques Dubois, Magali Barthelemy-Requin, Gaëlle Lenglet, Sabine Depauw, Thierry Cresteil, Geneviève Aubert, Valérie Monnier, Robert Kiss, Marie-Hélène David-Cordonnier, Jean-Louis Kraus.   

Abstract

A series of twenty six 8-hydroxyquinoline substituted amines, structurally related to compounds 2 and 3, were synthesized to evaluate the effects of structural changes on antitumor activity and understand their mechanism of action. The studies were performed on a wide variety of cancer cell lines within glioma and carcinoma models. The results obtained from chemical models and biological techniques such as microarrays suggest the following hypothesis that a quinone methide intermediate which does not react with DNA but which gives covalent protein thiol adducts. Micro-array analysis showed that the drugs induce the expression of a variety of stress related genes responsible for the cytotoxic and cytostatic effects in carcinoma and glioblastoma cells respectively. The described analogues could represent new promising anti-cancer candidates with specific action mechanisms, targeting accessible thiols from specific proteins and inducing potent anti-cancer effects. Copyright 2009 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19931949     DOI: 10.1016/j.ejmech.2009.11.006

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  6 in total

1.  JLK1486, a Bis 8-Hydroxyquinoline-Substituted Benzylamine, Displays Cytostatic Effects in Experimental Gliomas through MyT1 and STAT1 Activation and, to a Lesser Extent, PPARγ Activation.

Authors:  Céline Bruyère; Sébastien Madonna; Gwendoline Van Goietsenoven; Véronique Mathieu; Jean Dessolin; Jean-Louis Kraus; Florence Lefranc; Robert Kiss
Journal:  Transl Oncol       Date:  2011-06-01       Impact factor: 4.243

2.  JLK1486, a N,N-[(8-hydroxyquinoline)methyl]-substituted benzylamine analogue, inhibits melanoma proliferation and induces autophagy.

Authors:  T C Koekemoer; M van de Venter; J-L Kraus
Journal:  Cell Prolif       Date:  2014-08-20       Impact factor: 6.831

3.  Synthesis and anti-phytopathogenic activity of 8-hydroxyquinoline derivatives.

Authors:  Xiao-Dan Yin; Yu Sun; Raymond Kobla Lawoe; Guan-Zhou Yang; Ying-Qian Liu; Xiao-Fei Shang; Hua Liu; Yu-Dong Yang; Jia-Kai Zhu; Xiao-Ling Huang
Journal:  RSC Adv       Date:  2019-09-24       Impact factor: 4.036

4.  Characterization of Aminobenzylphenols as Protein Disulfide Isomerase Inhibitors in Glioblastoma Cell Lines.

Authors:  Andrea Shergalis; Ding Xue; Fatma Z Gharbia; Hannah Driks; Binita Shrestha; Amina Tanweer; Kirin Cromer; Mats Ljungman; Nouri Neamati
Journal:  J Med Chem       Date:  2020-09-11       Impact factor: 7.446

5.  Ruthenacarborane and Quinoline: A Promising Combination for the Treatment of Brain Tumors.

Authors:  Dijana Drača; Milan Marković; Marta Gozzi; Sanja Mijatović; Danijela Maksimović-Ivanić; Evamarie Hey-Hawkins
Journal:  Molecules       Date:  2021-06-22       Impact factor: 4.411

6.  ER stress in temozolomide-treated glioblastomas interferes with DNA repair and induces apoptosis.

Authors:  Jessica L Weatherbee; Jean-Louis Kraus; Alonzo H Ross
Journal:  Oncotarget       Date:  2016-07-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.